Glenmark Pharma gets approval from Health Canada for nasal spray Ryaltris

Glenmark Pharma gets approval from Health Canada for nasal spray Ryaltris Health Canada granted approval to partner Bausch Health Companies Inc and Glenmark Specialty SA, a subsidiary of the company, for Ryaltris (olopatadine hydrochloride and mometasone furoate nasal spray), Glenmark Pharmaceuticals said in a statement.

from Moneycontrol Business News https://ift.tt/OS9vqz6
Posted by: at
Tags:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Start-up Street: Social justice and the start-up ecosystem

Disparities in start-ups are a global phenomenon and affirmative action is needed to ensure an equal opportunities environment for aspiring...